Tricarbonyldichlororuthenium(II) dimer, a pharmacological CO donor, prevents ischemia reperfusion (I R)-induced oxidative damage to the gastric mucosa by enhancing gastric blood flow (GBF) and reducing DNA oxidation and systemic inflammatory response.